{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:14:06Z","timestamp":1780668846774,"version":"3.54.1"},"reference-count":92,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"African Research Excellence Fund","award":["AREF-328-EGWU-F-C1043"],"award-info":[{"award-number":["AREF-328-EGWU-F-C1043"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Surveillance of antimalarial drug efficacy is essential for drug policy in the fight against malaria. This includes clinical trials of drug efficacy, molecular marker typing and ex vivo\/in vitro drug susceptibility tests such as 50% inhibitory concentration (IC50) assay. The goal of this review was to elaborate on the variance in the IC50 assay across labs in sub-Saharan Africa (sSA) where malaria is endemic. We systematically reviewed 71 articles, published between 2015 and 2025, evaluating IC50 in sSA where only 56 were performed in labs in Western (WA), Central (CA), East (EA) and Southern Africa (SA). The IC50 values of the major antimalarial drugs, including dihydroartemisinin (DHA), lumefantrine (LUM), mefloquine (MFQ), amodiaquine (AMD), chloroquine (CQ), piperaquine (PPQ), artesunate (ATS), artemisinin (ART) and quinine (QN), were reported. An F-test performed on the IC50 values from WA and EA, where ex vivo assays were conducted, revealed a statistically significant variation (P value &amp;lt;0.05) in the IC50 values of some major antimalarials (DHA, CQ, LUM and AMD). The geometric means for DHA, CQ, LUM and AMD in WA versus EA were 2.46 versus 2.21, 83.15 versus 34.34, 10.06 versus 10.47, and 10.63 versus 17.61\u2005nM, respectively. The overall ex vivo IC50 values of CQ were generally below the known resistance thresholds. Differences in drug reconstitution solvents, the range of drug concentrations, period of drug exposure (48 or 72\u2005h), and curve-fitting tools and assay methods were observed. These differences together could account for the variance in IC50 values across sSA. We therefore recommend regional harmonization of the IC50 protocol for antimalarial drug efficacy surveillance and formation of a regional quality assessment network of malaria IC50 labs, as a step towards reliable data sharing and integration into strategic plans for malaria elimination.<\/jats:p>","DOI":"10.1093\/jac\/dkag187","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:57:20Z","timestamp":1778673440000},"source":"Crossref","is-referenced-by-count":0,"title":["Variance in IC50 in\n                    <i>in vitro<\/i>\n                    \/\n                    <i>ex vivo<\/i>\n                    antimalarial drug susceptibility assays in laboratories across Africa"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3408-5471","authenticated-orcid":false,"given":"Chinedu O","family":"Egwu","sequence":"first","affiliation":[{"name":"Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Disease Control and Elimination , Atlantic Boulevard, Fajara, PO Box 273, Banjul ,","place":["The Gambia"]},{"name":"Medical Biochemistry Department, College of Medicine, Alex-Ekwueme Federal University Ndufu-Alike , P.M.B. 1010, Ikwo 482131 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-2366","authenticated-orcid":false,"given":"Olusola","family":"Ajibaye","sequence":"additional","affiliation":[{"name":"Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Disease Control and Elimination , Atlantic Boulevard, Fajara, PO Box 273, Banjul ,","place":["The Gambia"]},{"name":"Nigerian Institute of Medical Research Department of Biochemistry and Nutrition, , 6, Edmund Crescent off Murtala Mohammed Way, Yaba, Lagos PMB 2013 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7911-6457","authenticated-orcid":false,"given":"Eniyou","family":"Oriero","sequence":"additional","affiliation":[{"name":"Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Disease Control and Elimination , Atlantic Boulevard, Fajara, PO Box 273, Banjul ,","place":["The Gambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndey Fatou","family":"Drammeh","sequence":"additional","affiliation":[{"name":"Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Disease Control and Elimination , Atlantic Boulevard, Fajara, PO Box 273, Banjul ,","place":["The Gambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1073-3956","authenticated-orcid":false,"given":"Ignatius C","family":"Ndong","sequence":"additional","affiliation":[{"name":"Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Disease Control and Elimination , Atlantic Boulevard, Fajara, PO Box 273, Banjul ,","place":["The Gambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatoumata","family":"Bojang","sequence":"additional","affiliation":[{"name":"Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Disease Control and Elimination , Atlantic Boulevard, Fajara, PO Box 273, Banjul ,","place":["The Gambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora N","family":"Nganyewo","sequence":"additional","affiliation":[{"name":"Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Disease Control and Elimination , Atlantic Boulevard, Fajara, PO Box 273, Banjul ,","place":["The Gambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4478-3601","authenticated-orcid":false,"given":"Alfred","family":"Amambua-Ngwa","sequence":"additional","affiliation":[{"name":"Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Disease Control and Elimination , Atlantic Boulevard, Fajara, PO Box 273, Banjul ,","place":["The Gambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"2026060509232398200_dkag187-B1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm.4381","article-title":"Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic","volume":"23","author":"Blasco","year":"2017","journal-title":"Nat Med"},{"key":"2026060509232398200_dkag187-B2","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1046\/j.1365-3156.2001.00819.x","article-title":"History and importance of antimalarial drug resistance","volume":"6","author":"D\u2019Alessandro","year":"2001","journal-title":"Trop Med Int Health"},{"key":"2026060509232398200_dkag187-B3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"2026060509232398200_dkag187-B4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/0020-7519(90)90198-V","article-title":"Chemotherapy and drug resistance in malaria","volume":"20","author":"Cowman","year":"1990","journal-title":"Int J Parasitol"},{"key":"2026060509232398200_dkag187-B5","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat Med"},{"key":"2026060509232398200_dkag187-B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.51015","article-title":"Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance","volume":"9","author":"Mathieu","year":"2020","journal-title":"Elife"},{"key":"2026060509232398200_dkag187-B7","first-page":"1","volume-title":"Encyclopedia of Malaria","author":"Na-Bangchang","year":"2019"},{"key":"2026060509232398200_dkag187-B8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/2229-5070.248695","article-title":"Drug susceptibility testing methods of antimalarial agents","volume":"8","author":"Maji","year":"2018","journal-title":"Trop Parasitol"},{"key":"2026060509232398200_dkag187-B9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00720-20","article-title":"Tolerance of Gambian Plasmodium falciparum to dihydroartemisinin and lumefantrine detected by ex vivo parasite survival rate assay","volume":"65","author":"Mbye","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060509232398200_dkag187-B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-03942-5","article-title":"Time to scale up molecular surveillance for anti-malarial drug resistance in sub-Saharan Africa","volume":"20","author":"Nsanzabana","year":"2021","journal-title":"Malar J"},{"key":"2026060509232398200_dkag187-B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-018-2185-9","article-title":"Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape","volume":"17","author":"Nsanzabana","year":"2018","journal-title":"Malar J"},{"key":"2026060509232398200_dkag187-B12","author":"WHO"},{"key":"2026060509232398200_dkag187-B13","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1093\/cid\/ciz740","article-title":"Serologic markers of previous malaria exposure and functional antibodies inhibiting parasite growth are associated with parasite kinetics following a Plasmodium falciparum controlled human infection","volume":"70","author":"Achan","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026060509232398200_dkag187-B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-015-0962-2","article-title":"Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay","volume":"14","author":"Linares","year":"2015","journal-title":"Malar J"},{"key":"2026060509232398200_dkag187-B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-015-0539-5","article-title":"Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations","volume":"13","author":"Duru","year":"2015","journal-title":"BMC Med"},{"key":"2026060509232398200_dkag187-B16","author":"Witkowski"},{"key":"2026060509232398200_dkag187-B17","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1093\/jac\/dkaa250","article-title":"Identification of compounds active against quiescent artemisinin-resistant Plasmodium falciparum parasites via the quiescent-stage survival assay (QSA)","volume":"75","author":"Reyser","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2026060509232398200_dkag187-B18","article-title":"Ring stage survival assays (RSA) to evaluate the in vitro and ex vivo susceptibility of Plasmodium falciparum to artemisinins","author":"Witkowski"},{"key":"2026060509232398200_dkag187-B19","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3201\/eid2110.150682","article-title":"Induction of multidrug tolerance in Plasmodium falciparum by extended artemisinin pressure","volume":"21","author":"M\u00e9nard","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2026060509232398200_dkag187-B20","doi-asserted-by":"publisher","first-page":"115865","DOI":"10.1016\/j.bmc.2020.115865","article-title":"The advantages of describing covalent inhibitor in vitro potencies by IC50 at a fixed time point. IC50 determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimization","volume":"29","author":"Thorarensen","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"2026060509232398200_dkag187-B21","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1039\/C4AN00338A","article-title":"Simple sample processing enhances malaria rapid diagnostic test performance","volume":"139","author":"Davis","year":"2014","journal-title":"Analyst"},{"key":"2026060509232398200_dkag187-B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-13-207","article-title":"Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change","volume":"13","author":"Tinto","year":"2014","journal-title":"Malar J"},{"key":"2026060509232398200_dkag187-B23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"2026060509232398200_dkag187-B24","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1128\/AAC.01636-09","article-title":"Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism","volume":"54","author":"Witkowski","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060509232398200_dkag187-B25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ab.2016.06.025","article-title":"Determination of half-maximal inhibitory concentration using biosensor-based protein interaction analysis","volume":"508","author":"Aykul","year":"2016","journal-title":"Anal Biochem"},{"key":"2026060509232398200_dkag187-B26","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.4269\/ajtmh.20-0235","article-title":"Molecular surveillance and in vitro drug sensitivity study of Plasmodium falciparum isolates from the China-Myanmar border","volume":"103","author":"Wang","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"2026060509232398200_dkag187-B27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4269\/ajtmh.1922.s1-2.289","article-title":"Some observations on the effect of quinine upon the growth of malaria plasmodia in vitro","volume":"s1-2","author":"Bass","year":"1922","journal-title":"Am J Trop Med Hyg"},{"key":"2026060509232398200_dkag187-B28","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.16.4.567","article-title":"The cultivation of malarial plasmodia (Plasmodium vivax and Plasmodium falciparum) in vitro","volume":"16","author":"Bass","year":"1912","journal-title":"J Exp Med"},{"key":"2026060509232398200_dkag187-B29","author":"Basco"},{"key":"2026060509232398200_dkag187-B30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0140-6736(78)90365-3","article-title":"Drug sensitivity of Plasmodium falciparum. An in-vitro microtechnique","volume":"1","author":"Rieckmann","year":"1978","journal-title":"Lancet"},{"key":"2026060509232398200_dkag187-B31","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/AAC.16.6.710","article-title":"Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique","volume":"16","author":"Desjardins","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060509232398200_dkag187-B32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/tropicalmed7100265","article-title":"Factors affecting the performance of HRP2-based malaria rapid diagnostic tests","volume":"7","author":"Marti\u00e1\u00f1ez-Vendrell","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"2026060509232398200_dkag187-B33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4269\/ajtmh.1993.48.739","article-title":"Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity","volume":"48","author":"Makler","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"2026060509232398200_dkag187-B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061606","article-title":"A novel flow cytometric hemozoin detection assay for real-time sensitivity testing of Plasmodium falciparum","volume":"8","author":"Rebelo","year":"2013","journal-title":"PLoS One"},{"key":"2026060509232398200_dkag187-B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-11-272","article-title":"A simple and inexpensive haemozoin-based colorimetric method to evaluate anti-malarial drug activity","volume":"11","author":"Men","year":"2012","journal-title":"Malar J"},{"key":"2026060509232398200_dkag187-B36","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060509232398200_dkag187-B37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1087057106295897","article-title":"Optimizing classification of drug-drug interaction potential for CYP450 isoenzyme inhibition assays in early drug discovery","volume":"12","author":"Krippendorff","year":"2007","journal-title":"J Biomol Screen"},{"key":"2026060509232398200_dkag187-B38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/pst.426","article-title":"Guidelines for accurate EC50\/IC50 estimation","volume":"10","author":"Sebaugh","year":"2011","journal-title":"Pharm Stat"},{"key":"2026060509232398200_dkag187-B39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12936-016-1173-1","article-title":"Analysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms","volume":"15","author":"Wirjanata","year":"2016","journal-title":"Malar J"},{"key":"2026060509232398200_dkag187-B40","author":"WHO"},{"key":"2026060509232398200_dkag187-B41","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1021\/acs.jcim.4c00049","article-title":"Combining IC50 or Ki values from different sources is a source of significant noise","volume":"64","author":"Landrum","year":"2024","journal-title":"J Chem Inf Model"},{"key":"2026060509232398200_dkag187-B42","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","article-title":"Increasing prevalence of artemisinin-resistant HRP2-negative malaria in Eritrea","volume":"389","author":"Mihreteab","year":"2023","journal-title":"N Engl J Med"},{"key":"2026060509232398200_dkag187-B43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12936-022-04051-7","article-title":"Plasmodium falciparum histidine-rich protein 2 and 3 genes deletion in global settings (2010-2021): a systematic review and meta-analysis","volume":"21","author":"Jejaw Zeleke","year":"2022","journal-title":"Malar J"},{"key":"2026060509232398200_dkag187-B44","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.pt.2020.08.008","article-title":"From circulation to cultivation: Plasmodium in vivo versus in vitro","volume":"36","author":"Brown","year":"2020","journal-title":"Trends Parasitol"},{"key":"2026060509232398200_dkag187-B45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40268-020-00313-4","article-title":"Ex-vivo sensitivity of Plasmodium falciparum to common anti-malarial drugs: the case of K\u00e9ni\u00e9roba, a malaria endemic village in Mali","volume":"20","author":"Traor\u00e9","year":"2020","journal-title":"Drugs R D"},{"key":"2026060509232398200_dkag187-B46","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1015957","article-title":"In vitro susceptibility profile of Plasmodium falciparum clinical isolates from Ghana to antimalarial drugs and polymorphisms in resistance markers","volume":"12","author":"Zhao","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2026060509232398200_dkag187-B47","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1038\/s41467-025-62810-x","article-title":"Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024","volume":"16","author":"Okitwi","year":"2025","journal-title":"Nat Commun"},{"key":"2026060509232398200_dkag187-B48","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02445-18","article-title":"Baseline ex vivo and molecular responses of Plasmodium falciparum isolates to piperaquine before implementation of dihydroartemisinin-piperaquine in Senegal","volume":"63","author":"Robert","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060509232398200_dkag187-B49","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jep.2015.04.014","article-title":"Clerodane diterpenes from Polyalthia longifolia (Sonn) Thw. var. pendula: potential antimalarial agents for drug resistant Plasmodium falciparum infection","volume":"169","author":"Gbedema","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"2026060509232398200_dkag187-B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117839","article-title":"The ethnopharmacological study of plant drugs used traditionally in Djibouti for malaria treatment","volume":"325","author":"Elmi","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"2026060509232398200_dkag187-B51","doi-asserted-by":"publisher","DOI":"10.1177\/2515690X211073709","article-title":"Anti-plasmodial, cytotoxic and antioxidant activities of selected Ghanaian medicinal plants","volume":"27","author":"Appiah-Opong","year":"2022","journal-title":"J Evid Based Integr Med"},{"key":"2026060509232398200_dkag187-B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.127855","article-title":"Design, synthesis and biological evaluation of mono- and bisquinoline methanamine derivatives as potential antiplasmodial agents","volume":"38","author":"Bokosi","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"2026060509232398200_dkag187-B53","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1021\/acs.jnatprod.0c01119","article-title":"Antiplasmodial oleanane triterpenoids from Terminalia albida root bark","volume":"84","author":"Bald\u00e9","year":"2021","journal-title":"J Nat Prod"},{"key":"2026060509232398200_dkag187-B54","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1039\/C8MD00608C","article-title":"Incorporation of an intramolecular hydrogen bonding motif in the side chain of antimalarial benzimidazoles","volume":"10","author":"Attram","year":"2019","journal-title":"Medchemcomm"},{"key":"2026060509232398200_dkag187-B55","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jep.2016.05.058","article-title":"Antiplasmodial, anti-complement and anti-inflammatory in vitro effects of Biophytum umbraculum Welw. traditionally used against cerebral malaria in Mali","volume":"190","author":"Austarheim","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"2026060509232398200_dkag187-B56","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/jac\/dkab133","article-title":"Plasmodium malariae and Plasmodium falciparum comparative susceptibility to antimalarial drugs in Mali","volume":"76","author":"Dembele","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2026060509232398200_dkag187-B57","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01516-17","article-title":"Changing antimalarial drug sensitivities in Uganda","volume":"61","author":"Rasmussen","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060509232398200_dkag187-B58","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1086\/375419","article-title":"Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi","volume":"187","author":"Kublin","year":"2003","journal-title":"J Infect Dis"},{"key":"2026060509232398200_dkag187-B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-03985-8","article-title":"The emergence of chloroquine-sensitive Plasmodium falciparum is influenced by selected communities in some parts of the Central Region of Ghana","volume":"20","author":"Asare","year":"2021","journal-title":"Malar J"},{"key":"2026060509232398200_dkag187-B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-018-2551-7","article-title":"Towards a re-emergence of chloroquine sensitivity in C\u00f4te d\u2019Ivoire?","volume":"17","author":"Dagnogo","year":"2018","journal-title":"Malar J"},{"key":"2026060509232398200_dkag187-B61","unstructured":"Hamid A, Abdelraheem MM, Acheampong MH \u00a0et al \u00a0Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples. Wellcome Open Res \u00a02023; 8: 22. 10.12688\/wellcomeopenres.18681.1"},{"key":"2026060509232398200_dkag187-B62","first-page":"21881","article-title":"Plasmodium malariae structure and genetic diversity in sub-Saharan Africa determined from microsatellite variants and linked SNPs in orthologues of antimalarial resistance genes","volume":"12","author":"Oriero","year":"2022","journal-title":"Sci Reports"},{"key":"2026060509232398200_dkag187-B63","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","article-title":"The emergence of artemisinin partial resistance in Africa: how do we respond?","volume":"24","author":"Rosenthal","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026060509232398200_dkag187-B64","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000004773","article-title":"Artemisinin-based combination therapies in Africa: efficacy, adherence, and future directions","author":"Obeagu","year":"2026","journal-title":"Ann Med Surg"},{"key":"2026060509232398200_dkag187-B65","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12936-023-04819-5","article-title":"In vitro delayed response to dihydroartemisinin of malaria parasites infecting sickle cell erythrocytes","volume":"23","author":"Gnondjui","year":"2024","journal-title":"Malar J"},{"key":"2026060509232398200_dkag187-B66","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12936-017-2142-z","article-title":"In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine","volume":"16","author":"Forkuo","year":"2017","journal-title":"Malar J"},{"key":"2026060509232398200_dkag187-B67","doi-asserted-by":"publisher","first-page":"6664711","DOI":"10.1155\/2021\/6664711","article-title":"Evaluation of the antimalarial activity of the leaf latex of Aloe weloensis (Aloaceae) against Plasmodium parasites","volume":"2021","author":"Amare","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"2026060509232398200_dkag187-B68","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jep.2016.03.036","article-title":"In vitro inhibition of Plasmodium falciparum early and late stage gametocyte viability by extracts from eight traditionally used South African plant species","volume":"185","author":"Moyo","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"2026060509232398200_dkag187-B69","doi-asserted-by":"publisher","first-page":"947203","DOI":"10.3389\/fmolb.2022.947203","article-title":"Inhibition of Plasmodium falciparum Hsp70-Hop partnership by 2-phenylthynesulfonamide","volume":"9","author":"Muthelo","year":"2022","journal-title":"Front Mol Biosci"},{"key":"2026060509232398200_dkag187-B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1087057112455219","article-title":"Theoretical and experimental relationships between percent inhibition and IC50 data observed in high-throughput screening","volume":"18","author":"Gubler","year":"2013","journal-title":"J Biomol Screen"},{"key":"2026060509232398200_dkag187-B71","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1128\/AAC.01144-06","article-title":"High-throughput Plasmodium falciparum growth assay for malaria drug discovery","volume":"51","author":"Baniecki","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060509232398200_dkag187-B72","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2021.08.016","article-title":"Resistance to artemisinin in falciparum malaria parasites: a redox-mediated phenomenon","volume":"S0891-5849","author":"Egwu","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"2026060509232398200_dkag187-B73","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11538-020-00746-7","article-title":"Comparison of drug inhibitory effects (IC50) in monolayer and spheroid cultures","volume":"82","author":"Berrouet","year":"2020","journal-title":"Bull Math Biol"},{"key":"2026060509232398200_dkag187-B74","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ijpddr.2017.07.001","article-title":"Plasmodium falciparum in vitro continuous culture conditions: a comparison of parasite susceptibility and tolerance to anti-malarial drugs throughout the asexual intra-erythrocytic life cycle","volume":"7","author":"Duffy","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2026060509232398200_dkag187-B75","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1128\/CMR.15.3.355-364.2002","article-title":"Cultivation of Plasmodium spp","volume":"15","author":"Schuster","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"2026060509232398200_dkag187-B76","author":"Thermo Fisher Scientific Inc"},{"key":"2026060509232398200_dkag187-B77","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1128\/JCM.37.3.700-705.1999","article-title":"In vitro culture and drug sensitivity assay of Plasmodium falciparum with nonserum substitute and acute-phase Sera","volume":"37","author":"Ringwald","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2026060509232398200_dkag187-B78","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.exppara.2006.12.003","article-title":"In vitro cultivation of Plasmodium falciparum: studies with modified medium supplemented with ALBUMAX II and various animal sera","volume":"116","author":"Srivastava","year":"2007","journal-title":"Exp Parasitol"},{"key":"2026060509232398200_dkag187-B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-12-386","article-title":"An alternative protocol for Plasmodium falciparum culture synchronization and a new method for synchrony confirmation","volume":"12","author":"Childs","year":"2013","journal-title":"Malar J"},{"key":"2026060509232398200_dkag187-B80","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/345876","article-title":"A new method for culturing Plasmodium falciparum shows replication at the highest erythrocyte densities","volume":"187","author":"Li","year":"2003","journal-title":"J Infect Dis"},{"key":"2026060509232398200_dkag187-B81","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.3390\/ijms21134799","article-title":"Oxidation of erythrocytes enhances the production of reactive species in the presence of artemisinins","volume":"21","author":"Tsamesidis","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026060509232398200_dkag187-B82","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/antiox10121872","article-title":"Reactive oxygen species as the brainbox in malaria treatment","volume":"10","author":"Egwu","year":"2021","journal-title":"Antioxidants"},{"key":"2026060509232398200_dkag187-B83","first-page":"361","article-title":"Cultivation of erythrocytic stages","volume":"55","author":"Trager","year":"1977","journal-title":"Bull World Health Organ"},{"key":"2026060509232398200_dkag187-B84","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1600-079X.1999.tb00602.x","article-title":"Melatonin protects human red blood cells from oxidative hemolysis: new insights into the radical-scavenging activity","volume":"27","author":"Tesoriere","year":"1999","journal-title":"J Pineal Res"},{"key":"2026060509232398200_dkag187-B85","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/antiox11040747","article-title":"Hemoglobin oxidation reactions in stored blood","volume":"11","author":"Alayash","year":"2022","journal-title":"Antioxidants"},{"key":"2026060509232398200_dkag187-B86","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/bjh.13882","article-title":"Biopreservation of RBCs for in vitro Plasmodium falciparum culture","volume":"175","author":"Goheen","year":"2016","journal-title":"Br J Haematol"},{"key":"2026060509232398200_dkag187-B87","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/00034983.1998.11813260","article-title":"Rosetting characteristics of uninfected erythrocytes from healthy individuals and malaria patients","volume":"92","author":"Chotivanich","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"2026060509232398200_dkag187-B88","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1006\/expr.1994.1098","article-title":"In vitro development of infectious liver stages of P. Yoelii and P. Berghei malaria in human cell lines","volume":"79","author":"Calvo-Calle","year":"1994","journal-title":"Exp Parasitol"},{"key":"2026060509232398200_dkag187-B89","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1385\/0-89603-239-6:43","article-title":"Simple in vitro cultivation of the malaria parasite Plasmodium falciparum (erythrocytic stages) suitable for large-scale preparations","volume":"21","author":"Read","year":"1993","journal-title":"Methods Mol Biol"},{"key":"2026060509232398200_dkag187-B90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-26559-2","article-title":"An in vitro erythrocyte preference assay reveals that Plasmodium falciparum parasites prefer type O over type A erythrocytes","volume":"8","author":"Theron","year":"2018","journal-title":"Sci Rep"},{"key":"2026060509232398200_dkag187-B91","doi-asserted-by":"publisher","first-page":"14974","DOI":"10.1038\/s41598-018-33226-z","article-title":"A reference document on permissible limits for solvents and buffers during in vitro antimalarial screening","volume":"8","author":"Naidu","year":"2018","journal-title":"Sci Rep"},{"key":"2026060509232398200_dkag187-B92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143565","article-title":"The genotypic and phenotypic stability of Plasmodium falciparum field isolates in continuous in vitro culture","volume":"11","author":"Yeda","year":"2016","journal-title":"PLoS One"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/7\/dkag187\/68478904\/dkag187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/7\/dkag187\/68478904\/dkag187.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:23:29Z","timestamp":1780665809000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag187\/8702789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":92,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag187","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,6,3]]},"article-number":"dkag187"}}